U-Blot® Research Grade Anti-Human CD22 (ADCT-602)Cat. No. WA1420Request quote
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade Anti-Human CD22 (ADCT-602)Cat. No. WA1420
U-Blot® Research Grade Anti-Human CD217/IL17RA (ZL 1102)Cat. No. WA1419
U-Blot® Research Grade Anti-Human CD217/IL17RA (OSE-703)Cat. No. WA1418
U-Blot® Research Grade Anti-Human CD213a1/IL13RA1 Antibody (MK-6105)Cat. No. WA1417
U-Blot® Research Grade Anti-Human CD205/LY75/DEC-205 (MEN1309)Cat. No. WA1416
U-Blot® Research Grade Anti-Human CD205/LY75/DEC-205 (CDX-1401)Cat. No. WA1415
U-Blot® Research Grade Anti-Human CD205/LY75 (OX-002)Cat. No. WA1414
U-Blot® Research Grade Anti-Human CD203c/ENPP3 (AGS-16C3F)Cat. No. WA1413
U-Blot® Research Grade Anti-Human CD203c/ENPP3 & CD3 (XmAb819)Cat. No. WA1412
U-Blot® Research Grade Anti-Human CD202b/TEK/TIE-2 (UBX2050)Cat. No. WA1411
U-Blot® Research Grade Anti-Human CD200R1/OX2R Antibody (I-4P)Cat. No. WA1410
U-Blot® Research Grade Anti-Human CD200R1/OX2R Antibody (huDX182)Cat. No. WA1409